JASON CALLOWAY: Open Payments
NPI 1730728841 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$275 in 9 payments from 4 companies in 2025. Trend: 2023 $1,922 · 2024 $417 · 2025 $275
Food & beverage: $275
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $190 |
| ViiV Healthcare Company | 2 | $47 |
| Daiichi Sankyo Inc. | 1 | $23 |
| ABBVIE INC. | 1 | $15 |
Products named: CAPLYTA, DOVATO, INJECTAFER, VRAYLAR.
Industry payments across NV — which companies pay providers there.
